| Tag | Content |
|---|
EnhancerAtlas ID | HS150-07085 |
Organism | Homo sapiens |
Tissue/cell | NT2-D1 |
Coordinate | chr21:47829710-47830460 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SOX10 | MA0442.2 | chr21:47830200-47830211 | TCCTTTGTTTT | - | 6.32 | | Sox3 | MA0514.1 | chr21:47830201-47830211 | CCTTTGTTTT | + | 6.02 | | Stat6 | MA0520.1 | chr21:47830257-47830272 | TAGTTCCAGAGAAAC | + | 6.19 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_68992 | chr21:47829379-47830252 | H9 | | SE_68992 | chr21:47830338-47833703 | H9 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr21 | 47829867 | 47830247 | | chr21 | 47830065 | 47830240 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH21I046409 | chr21 | 47829380 | 47830252 | | GH21I046410 | chr21 | 47830339 | 47833703 |
|
Enhancer Sequence | TCGGCCAGGC TGATCTTGAA CTCCTGTGCT CAAGTGATCT GCCTGCCTCA GCCTCCCAAA 60
GTGCTGGGGT TACAGACGTG AGCCACCGCG CCCGGCCTCA GTTCACTGAT TTCAGGTTTT 120
GGTGTTTTAC ATTTAGAGCT ACCTTCGTAT GCTGGCTCCA GTATTTTAAC GTGATATATG 180
CGTTGTGATT ATGACCGTCT TCAGTGCGCA CCCCTTGATT CCAGTTTATT TAGTGCATTT 240
AGGGAATGAG CAGAAGCTGC GTATAATCAG AATTGTCCTC GAAATTCCTT CGCGTGCCTG 300
TAGAGTACAG AGACAACGGC CGGTGCCGCA CACAGTAAGG CACGCGACGG GGAGCAGAAT 360
GTGCAGCGGG CATTCCTAGC CCGCAGCTGG GAGGCTGCTT TTGCTAAATG CATGGTGTTG 420
TTCATCGGTG GTAAATGCAT AGGAAGGTGT TGTTGACAGC GTCCAAACCA AAGCCACAGG 480
TTCATCCGGT TCCTTTGTTT TTTTTCTGTA GGCCAGATTT GCATTTGAGT CCAGAGTAAT 540
TGTGAGGTAG TTCCAGAGAA ACCTGGAGTT GTTATGAAAC CCTCAGTTTT TTGGAAGAAC 600
ATATTAGTCT ATAACAAATA GTTTTAAAAT TGTTAGAGCA CAAATGGATT AGAATTTTTC 660
TATTTTTTGT CATTACCAGG AATGTTATCT TAAGAGAATA GAGTTTGGAG CTATATTGAC 720
ATACATCTCA ATCCTAATTT TCCACTTACT 750
|
